DK2231131T3 - Formuleringer af organiske platinforbindelser i tilstedeværelsen af associative polymerer, således opnåede produkter og anvendelser deraf - Google Patents

Formuleringer af organiske platinforbindelser i tilstedeværelsen af associative polymerer, således opnåede produkter og anvendelser deraf

Info

Publication number
DK2231131T3
DK2231131T3 DK08840675.6T DK08840675T DK2231131T3 DK 2231131 T3 DK2231131 T3 DK 2231131T3 DK 08840675 T DK08840675 T DK 08840675T DK 2231131 T3 DK2231131 T3 DK 2231131T3
Authority
DK
Denmark
Prior art keywords
formulations
platinum compounds
associative polymers
obtained products
organic platinum
Prior art date
Application number
DK08840675.6T
Other languages
English (en)
Inventor
Olivier Guerret
Jean-Marc Suau
Original Assignee
Coatex Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coatex Sas filed Critical Coatex Sas
Application granted granted Critical
Publication of DK2231131T3 publication Critical patent/DK2231131T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/282Platinum compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/80Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F290/00Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
    • C08F290/02Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated end groups
    • C08F290/06Polymers provided for in subclass C08G
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F290/00Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
    • C08F290/02Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated end groups
    • C08F290/06Polymers provided for in subclass C08G
    • C08F290/061Polyesters; Polycarbonates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F290/00Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
    • C08F290/02Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated end groups
    • C08F290/06Polymers provided for in subclass C08G
    • C08F290/062Polyethers
DK08840675.6T 2007-10-19 2008-10-07 Formuleringer af organiske platinforbindelser i tilstedeværelsen af associative polymerer, således opnåede produkter og anvendelser deraf DK2231131T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0707306A FR2922452B1 (fr) 2007-10-19 2007-10-19 Formulations de composes organoplatiniques en presence de polymeres associatifs, produits obtenus et leurs utilisations
PCT/IB2008/002669 WO2009050555A2 (fr) 2007-10-19 2008-10-07 Formulations de composes organoplatiniques en presence de polymeres associatifs, produits obtenus et leurs utilisations

Publications (1)

Publication Number Publication Date
DK2231131T3 true DK2231131T3 (da) 2011-04-26

Family

ID=39431012

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08840675.6T DK2231131T3 (da) 2007-10-19 2008-10-07 Formuleringer af organiske platinforbindelser i tilstedeværelsen af associative polymerer, således opnåede produkter og anvendelser deraf

Country Status (11)

Country Link
US (1) US20100278925A1 (da)
EP (1) EP2231131B1 (da)
JP (1) JP2011500660A (da)
CN (1) CN101827587A (da)
AT (1) ATE495734T1 (da)
DE (1) DE602008004675D1 (da)
DK (1) DK2231131T3 (da)
ES (1) ES2362559T3 (da)
FR (1) FR2922452B1 (da)
IL (1) IL204427A (da)
WO (1) WO2009050555A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA116535C2 (uk) 2012-03-30 2018-04-10 Рдінновейшн Апс Сполуки бензолполікарбонових кислот та їх застосування як лікарських засобів
FR3107667A1 (fr) 2020-02-27 2021-09-03 Melchior Material And Life Science France Doses unitaires pour la liberation d’une formulation aqueuse

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US290969A (en) * 1883-12-25 Device for handling spooled barbed wire
US361629A (en) * 1887-04-19 Friction-clutch pulley
US277113A (en) * 1883-05-08 Air-gas machine
US277120A (en) * 1883-05-08 Island
US284544A (en) * 1883-09-04 Othniel b
US277116A (en) * 1883-05-08 Daniel conboy
US255326A (en) * 1882-03-21 ordway
US277108A (en) * 1883-05-08 Clamp for sewing-machine attachments
US356004A (en) * 1887-01-11 Combined wood
US257623A (en) * 1882-05-09 John m
US361505A (en) * 1887-04-19 Folding portable tent
US312834A (en) * 1885-02-24 Device for milking cows
US361615A (en) * 1887-04-19 Chair
US277118A (en) * 1883-05-08 Apparatus for operating railway-signals
US361643A (en) * 1887-04-19 William phillips
US290983A (en) * 1883-12-25 bbanson
US255325A (en) * 1882-03-21 Oastler
US273996A (en) * 1883-03-13 Oheistopher hymees
US312820A (en) * 1885-02-24 Barb-fence machine
US290955A (en) * 1883-12-25 Half to charles green
US312876A (en) * 1885-02-24 Saloon-hopper tube for keeping clean saloon-hoppers in railroad-cars
US257621A (en) * 1882-05-09 And chaeles e
US255323A (en) * 1882-03-21 Israel e
US312848A (en) * 1885-02-24 Watch
US324919A (en) * 1885-08-25 Liniment
US257622A (en) * 1882-05-09 John w
FR2633930B1 (fr) * 1988-07-07 1991-04-19 Coatex Sa Agent epaississant modificateur des caracteristiques rheologiques de compositions aqueuses chargees et/ou pigmentees, blanches ou colorees
ES2290074T3 (es) * 1993-07-19 2008-02-16 Angiotech Pharmaceuticals, Inc. Composiciones anti-angiogenicas que contienen taxol y un vehiculo no biodegradable y su uso.
US20030203976A1 (en) * 1993-07-19 2003-10-30 William L. Hunter Anti-angiogenic compositions and methods of use
US6004573A (en) * 1997-10-03 1999-12-21 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US6861397B2 (en) * 1999-06-23 2005-03-01 The Dial Corporation Compositions having enhanced deposition of a topically active compound on a surface
WO2002026241A1 (fr) * 2000-09-26 2002-04-04 Center For Advanced Science And Technology Incubation, Ltd. Micelle polymere renfermant du cisplatine et utilisation
US7094810B2 (en) * 2001-06-08 2006-08-22 Labopharm, Inc. pH-sensitive block copolymers for pharmaceutical compositions
DE60128011T2 (de) * 2001-10-29 2007-12-27 Dendritic Nanotechnologies, Inc., Mt. Pleasant Abgabesystem für antineoplastische arzneistoffe auf basis dendritischer polymere
FR2846978B1 (fr) * 2002-11-08 2007-05-18 Coatex Sas Utilisation d'un copolymere disposant d'au moins une fonction greffee alkoxy ou hydroxy polyalkylene glycol, comme agent ameliorant l'activation de l'azurage optique et produits obtenus
AU2004241830B9 (en) * 2003-05-26 2010-04-22 Hiroshi Maeda Antitumor agent and process for producing the same
AU2004261063A1 (en) * 2003-08-04 2005-02-10 Foamix Ltd. Foam carrier containing amphiphilic copolymeric gelling agent

Also Published As

Publication number Publication date
EP2231131A2 (fr) 2010-09-29
CN101827587A (zh) 2010-09-08
DE602008004675D1 (de) 2011-03-03
WO2009050555A2 (fr) 2009-04-23
EP2231131B1 (fr) 2011-01-19
ATE495734T1 (de) 2011-02-15
US20100278925A1 (en) 2010-11-04
IL204427A (en) 2013-10-31
ES2362559T3 (es) 2011-07-07
FR2922452A1 (fr) 2009-04-24
WO2009050555A3 (fr) 2009-06-04
FR2922452B1 (fr) 2010-01-22
JP2011500660A (ja) 2011-01-06

Similar Documents

Publication Publication Date Title
CY1115082T1 (el) Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπανιου, παρασκευες και χρησεις αυτων
UY30759A1 (es) Compuestos quimicos
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
UY30578A1 (es) Nuevos derivados de 2,4??- y 3, 4??-bipiridina sustituidos, procedimientos para su preparacion, medicamentos conteniéndolos y aplicaciones
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
MA32394B1 (fr) Composes pegyles d'insuline lispro
NO20090348L (no) Substituerte imidazolonderivater, sammensetninger og anvendelser av samme, samt fremgangsmater for fremstilling av samme
CY1116111T1 (el) Τοπικη συνθεση για τη θεραπεια της ακτινικης κερατωσης
FR2912310B1 (fr) Nouvelles compositions cosmetiques et/ou pharmaceutiques et leurs applications.
WO2010067078A3 (en) 3,6-disubstituted xanthylium salts as medicaments
EA200801580A1 (ru) Новые производные пирониндола и способ их получения
CY1116840T1 (el) Χρηση 24-norudca
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
BRPI0408848B8 (pt) composições farmacêuticas de complexo de ciclodextrina-cladribina complexo, usos do referido complexo, bem como processos para a sua preparação
WO2010080414A3 (en) Substituted fno (2-[furan-2-yl] naphthalen-1-ol) derivatives as anti-cancer agents
DK2231131T3 (da) Formuleringer af organiske platinforbindelser i tilstedeværelsen af associative polymerer, således opnåede produkter og anvendelser deraf
ECSP088464A (es) Compuesto para la inhibición de la apoptosis
ITFI20060255A1 (it) Composizione agrochimica, e metodo di trattamento di vegetali conmprendente la somministrazione di tale composizione
CY1108865T1 (el) Υποκατεστημενες 2,5-διαμινομευθυλο-1η-πυρρολες
TH1801007841A (th) อนุพันธ์ของ [1, 2, 3]ไตรอะโซโล[4, 5-d]ไพริมิดีนที่มีสัมพรรคภาพสำหรับรีเซปเตอร์ของแคนนาบินอยด์ประเภท 2
TH167729A (th) 2-แอมิโน-6-เมทิล-4,4a,5,6-เตตระไฮโดรไพราโน[3,4-d][1,3]ไทอะซิน-8a(8H)-อิล-1,3-ไทอะโซล-4-อิลเอไมด์
TH101434A (th) อนุพันธ์ 7-อัลไคนิล-1,8-แนพธิริโดน, การเตรียมสารนี้และการใช้สารนี้ในการรักษาโรค
CY1117126T1 (el) Σφαιριδια φορεα, μεθοδος για την παραγωγη τους και τη χρηση τους
UA118493C2 (uk) Конденсовані 1,2,4-тіадіазепіни та спосіб їх отримання
TH81754A (th) ตัวยาเกี่ยวกับเมอร์ทาซาพีนสำหรับรักษาอาการร้อนวูบวาบ